These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15697101)

  • 1. Correspondence regarding levalbuterol and racemic albuterol, July 2004 Supplement.
    Weiner AL
    Am J Manag Care; 2005 Jan; 11(1):53; author reply 54. PubMed ID: 15697101
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
    Schreck DM; Babin S
    Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?
    Asmus MJ; Hendeles L
    Pharmacotherapy; 2000 Feb; 20(2):123-9. PubMed ID: 10678290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost effectiveness of levalbuterol versus racemic albuterol.
    Quinn C
    Am J Manag Care; 2004 Jul; 10(5 Suppl):S153-7. PubMed ID: 15354680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of using levalbuterol in the emergency room.
    Bye MR
    J Pediatr; 2004 Sep; 145(3):422; author reply 422-3. PubMed ID: 15372720
    [No Abstract]   [Full Text] [Related]  

  • 7. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to make easier the treatment of asthma].
    Ait-Khaled N
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S76-10S79. PubMed ID: 17127972
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy of levalbuterol and racemic albuterol in the treatment of asthma.
    Chowdhury BA
    J Allergy Clin Immunol; 2002 Aug; 110(2):324; author reply 325-8. PubMed ID: 12170276
    [No Abstract]   [Full Text] [Related]  

  • 10. Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.
    Asmus MJ; Hendeles L; Weinberger M; Ahrens RC; Bisgaard H; Lötvall J; O'Byrne PM; Cockcroft DW
    J Allergy Clin Immunol; 2002 Aug; 110(2):325; author reply 325-8. PubMed ID: 12170277
    [No Abstract]   [Full Text] [Related]  

  • 11. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries.
    Aït-Khaled N; Auregan G; Bencharif N; Camara LM; Dagli E; Djankine K; Keita B; Ky C; Mahi S; Ngoran K; Pham DL; Sow O; Yousser M; Zidouni N; Enarson DA
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):268-71. PubMed ID: 10751075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
    Truitt T; Witko J; Halpern M
    Chest; 2003 Jan; 123(1):128-35. PubMed ID: 12527613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A levalbuterol metered-dose inhaler (Xopenex HFA) for asthma.
    Med Lett Drugs Ther; 2006 Mar; 48(1230):21-2, 24. PubMed ID: 16543879
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
    Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
    Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-isomer levalbuterol: a review of the acute data.
    Nowak R
    Curr Allergy Asthma Rep; 2003 Mar; 3(2):172-8. PubMed ID: 12562558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma.
    Qureshi F; Zaritsky A; Welch C; Meadows T; Burke BL
    Ann Emerg Med; 2005 Jul; 46(1):29-36. PubMed ID: 15988423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the cost-effectiveness of omalizumab.
    Campbell JD; Spackman DE; Sullivan SD
    Allergy; 2007 Dec; 62(12):1469. PubMed ID: 17983382
    [No Abstract]   [Full Text] [Related]  

  • 18. Omalizumab for severe allergic asthma: dollars and sense.
    Krishnan JA; Gould M
    J Allergy Clin Immunol; 2007 Nov; 120(5):1015-7. PubMed ID: 17983869
    [No Abstract]   [Full Text] [Related]  

  • 19. Questioning the economic evaluation of omalizumab.
    Revicki D; Brown R; Dale P
    J Allergy Clin Immunol; 2008 Jun; 121(6):1514; author reply 1514-5. PubMed ID: 18395781
    [No Abstract]   [Full Text] [Related]  

  • 20. Levalbuterol is not more cost-effective than albuterol for COPD.
    Hendeles L; Hartzema A
    Chest; 2003 Sep; 124(3):1176; author reply 1176-8. PubMed ID: 12970057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.